div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imagea href=https:reader042vdocumentinreader042viewer20220412125dd140c2d6be591ccb64f48dhtml5page1jpg target=_blank img data-url=atlas-venture-transforming-cancer-treatment-o-atlas-venture-transforming-cancerhtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: ATLAS VENTURE TRANSFORMING CANCER TREATMENT o … · ATLAS VENTURE TRANSFORMING CANCER TREATMENT o SURFACE ONCOLOGY *FACE NaSdaq SURFACE ONCOLOGY THE TUMOR MICROENVIRONMENT COMPANY loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentinreader042viewer20220412125dd140c2d6be591ccb64f48dhtml5thumbnails1jpg width=140 height=200 adivdiv class=annotationa href=https:atlasventurecom rel=ugc nofollow target=_blankhttps:atlasventurecomadiv div class=annotationa href=https:atlasventurecom rel=ugc nofollow target=_blankhttps:atlasventurecomadiv div class=annotationa href=https:twittercomatlasventure rel=ugc nofollow target=_blankhttps:twittercomatlasventureadiv div class=annotationa href=https:investorssurfaceoncologycomnews-releasesnews-release-detailssurface-oncology-announces-closing-1195-million-aggregate rel=ugc nofollow target=_blankhttps:investorssurfaceoncologycomnews-releasesnews-release-detailssurface-oncology-announces-closing-1195-million-aggregateadiv div class=annotationa href=https:investorsunumrxcomnews-releasesnews-release-detailsunum-therapeutics-announces-closing-initial-public-offering-and rel=ugc nofollow target=_blankhttps:investorsunumrxcomnews-releasesnews-release-detailsunum-therapeutics-announces-closing-initial-public-offering-andadiv div class=annotationa href=https:atlasventurecom rel=ugc nofollow target=_blankhttps:atlasventurecomadivdiv